A quinazoline derivative which is an alpha-1-selective adrenoceptor blocking agent used on once-a-day basis for therapy of mild-to-moderate hypertension. Terazosin is indicated for the treatment of symptomatic benign prostatic hyperplasia (BPH). Reference standards of Terazosin Hydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
stdClass Object ( [pname] => Terazosin Hydrochloride - API Standards [catalogue_number] => PA 20 3610000 [category_ids] => ,70,75,76,78,82, [chemical_name] => [weight] => 423.9 [form] => C19H26ClN5O4 [cas] => 63074-08-8 [pslug] => 63074-08-8-terazosin-hydrochloride-api-pa203610000 [latest_product] => 0 [linkproducts] => 1 [offers_id] => [offers_name] => [offers_status] => [offers_start_date] => [offers_end_date] => [pageview] => [offers_slug] => [offers_product_id] => [offers_product_code] => [offers_master_id] => [offer_percentage] => [offers_product_main_cat] => )
Catalogue No.:PA 20 3610000
CAS :
Molecular Formula : C19H26ClN5O4
Molecular Weight : 423.9
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....